Skip to content
10-K

Annual Report

SPECTRUM PHARMACEUTICALS INC

0000831547-23-000007

← back to feed
Filed
Mar 31, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 22, 2023 205.3M sh
Shares Diluted FY 2022 · Dec 31, 2022 183.24M sh
Shares Diluted FY 2022 · Dec 31, 2021 154.86M sh
Capex FY 2022 · Dec 31, 2022 $273K
Capex FY 2022 · Dec 31, 2021 $221K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$96.99M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$119.49M
Long Term Debt FY 2022 · Dec 31, 2022 $28.67M
Short Term Investments FY 2022 · Dec 31, 2022 $34.73M
Short Term Investments FY 2022 · Dec 31, 2021 $12.11M
Cash And Equivalents FY 2022 · Dec 31, 2022 $40.37M
Cash And Equivalents FY 2022 · Dec 31, 2021 $88.54M
Stockholders Equity FY 2022 · Dec 31, 2022 $27.89M
Stockholders Equity FY 2022 · Dec 31, 2021 $47.55M
Stockholders Equity FY 2022 · Dec 31, 2020 $134.24M
Current Liabilities FY 2022 · Dec 31, 2022 $42.69M
Current Liabilities FY 2022 · Dec 31, 2021 $53.23M
Total Liabilities FY 2022 · Dec 31, 2022 $75.45M
Total Liabilities FY 2022 · Dec 31, 2021 $64M
Current Assets FY 2022 · Dec 31, 2022 $101.01M
Current Assets FY 2022 · Dec 31, 2021 $103.95M
Total Assets FY 2022 · Dec 31, 2022 $103.34M
Total Assets FY 2022 · Dec 31, 2021 $111.55M
Eps Diluted FY 2022 · Dec 31, 2022 −$0.41
Eps Diluted FY 2022 · Dec 31, 2021 −$1.02
Eps Basic FY 2022 · Dec 31, 2022 −$0.41
Eps Basic FY 2022 · Dec 31, 2021 −$1.02
Sga Expense FY 2022 · Dec 31, 2022 $38.82M
Sga Expense FY 2022 · Dec 31, 2021 $60.41M
Rd Expense FY 2022 · Dec 31, 2022 $42.2M
Rd Expense FY 2022 · Dec 31, 2021 $87.3M
Net Income FY 2022 · Dec 31, 2022 −$75.4M
Net Income FY 2022 · Dec 31, 2021 −$158.63M
Operating Income FY 2022 · Dec 31, 2022 −$72.7M
Operating Income FY 2022 · Dec 31, 2021 −$147.7M
Revenue FY 2022 · Dec 31, 2022 $10.11M
Revenue FY 2022 · Dec 31, 2021 $0